Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

SANUWAVE Health (SNWV) Preferred Shares Issued (2020)

SANUWAVE Health has reported Preferred Shares Issued over the past 1 years, most recently at $200000.0 for Q2 2020.

Quarterly Preferred Shares Issued changed N/A to $200000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $200000.0 through Mar 2021, down 91.11% year-over-year, with the annual reading at $2.4 million for FY2020, N/A changed from the prior year.
Preferred Shares Issued was $200000.0 for Q2 2020 at SANUWAVE Health, down from $2.2 million in the prior quarter.
Over five years, Preferred Shares Issued peaked at $2.2 million in Q1 2020 and troughed at $200000.0 in Q2 2020.